TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:41
180 Life Sciences Corp. ( ATNF ) https://180lifesciences.com
0.17USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-86.36%
ATNF
SPY
30.72%
-99.71%
ATNF
SPY
112.82%
-99.92%
ATNF
SPY
201.04%
ATNF
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1.34
-0.63
0.28
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.03
0.00
-9.00
0.00
0.00
0.04
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
0.00
0.00
0.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.9522
-49.69
-64.71
1.23
Other Earnings and Cash Flow Stats:
180 Life Sciences Corp. ( ATNF ) Net Income TTM ($MM) is -75.66
180 Life Sciences Corp. ( ATNF ) Operating Income TTM ($MM) is -18.04
180 Life Sciences Corp. ( ATNF ) Owners' Earnings Annual ($MM) is 0.00
180 Life Sciences Corp. ( ATNF ) Current Price to Owners' Earnings ratio is 0.00
180 Life Sciences Corp. ( ATNF ) EBITDA TTM ($MM) is -17.94
180 Life Sciences Corp. ( ATNF ) EBITDA Margin is 0.00%
Capital Allocation:
180 Life Sciences Corp. ( ATNF ) has paid 0.00 dividends per share and bought back -5.992867 million shares in the past 12 months
180 Life Sciences Corp. ( ATNF ) has reduced its debt by 0.156436 million USD in the last 12 months
Capital Structure:
180 Life Sciences Corp. ( ATNF ) Interest-bearing Debt ($MM) as of last quarter is 0
180 Life Sciences Corp. ( ATNF ) Annual Working Capital Investments ($MM) are 0
180 Life Sciences Corp. ( ATNF ) Book Value ($MM) as of last quarter is -1
180 Life Sciences Corp. ( ATNF ) Debt/Capital as of last quarter is -461%
Other Balance Sheet Stats:
180 Life Sciences Corp. ( ATNF ) has 2 million in cash on hand as of last quarter
180 Life Sciences Corp. ( ATNF ) has 4 million of liabilities due within 12 months, and long term debt 0 as of last quarter
180 Life Sciences Corp. ( ATNF ) has 7 common shares outstanding as of last quarter
180 Life Sciences Corp. ( ATNF ) has 0 million USD of preferred stock value
Academic Scores:
180 Life Sciences Corp. ( ATNF ) Altman Z-Score is -47.56 as of last quarter
180 Life Sciences Corp. ( ATNF ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
180 Life Sciences Corp. ( ATNF ) largest shareholder is Tower Research Capital LLC owning 9634 shares at 0.00 ($MM) value
Jr. Donald A Mcgovern(an insider) Bought 10000 shares of 180 Life Sciences Corp. ( ATNF ) for the amount of $11500.00 on 2023-05-31
5.13% of 180 Life Sciences Corp. ( ATNF ) is held by insiders, and 9.67% is held by institutions
180 Life Sciences Corp. ( ATNF ) went public on 2017-06-27
Other 180 Life Sciences Corp. ( ATNF ) financial metrics:
FCF:-12.17
Unlevered Free Cash Flow:0.00
EPS:-5.16
Operating Margin:0.00
Gross Profit Margin:0.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:27498.74
Beta:1.23
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About 180 Life Sciences Corp. ( ATNF ) :
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.